Akynzeo 300-0.5 MG capsules
Ended Awarded Last action
- Contract number
- SPE2DR26F20LF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,337
Award facts
- Contract value 100% obligated
- $12,336.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,336.84 to AmerisourceBergen Drug Corp for the supply of AKYNZEO 300-0.5 mg capsules, an anti-nausea medication commonly used in oncology and chemotherapy settings. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by January 9, 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a critical pharmaceutical distributor supporting federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and Department of Defense healthcare programs worldwide. The contract structure demonstrates the Defense Logistics Agency's reliance on established vendor relationships to efficiently procure essential pharmaceutical products for military personnel and veterans across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F20LF?
SPE2DR26F20LF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F20LF worth?
The government has obligated $12,337 on SPE2DR26F20LF.
Is contract SPE2DR26F20LF an order under another contract?
Yes. SPE2DR26F20LF is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20LF competed?
The extent of competition for SPE2DR26F20LF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award